<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zarifyan, Alla</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Markus, Hugh S.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">CADISS Revealed Low Recurrent Stroke Rate in Patients With Cervical Artery Dissection</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">10-11</style></pages><abstract><style  face="normal" font="default" size="100%">The CADISS trial investigated the efficacy of antiplatelet vs anticoagulant treatment in preventing stroke in patients with acute cervical artery dissection. The feasibility phase revealed that the sample size for a definitive study would have to be approximately 10 000 patients. However, it showed that recurrent stroke rate was much lower than previously reported.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>